Carasent ASA Stock OTC Markets
Stocks
APXZF
NO0010123060
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 06-11 | Lannebo Hälsa och Ny Teknik rose 3.6 percent in May: Raysearch Laboratories, Sectra, and Bioinvent contributed positively | FW |
| 06-09 | Carasent completes acquisition of Infosolutions | FW |
| Market Cap | 1.59B 167M 144M 133M 125M 232M 15.93B 236M 1.57B 612M 7.75B 629M 615M 26.75B | P/E Ratio 2026 * |
52.9x | P/E Ratio 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.49B 157M 136M 125M 117M 218M 14.97B 222M 1.47B 575M 7.28B 591M 578M 25.14B | EV / Sales 2026 * |
3.75x | EV / Sales 2027 * | 2.98x |
| Free-Float |
66.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Carasent ASA
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 168M | |
| -1.24% | -7.57% | -43.54% | -16.41% | 25.92B | |
| +0.74% | -0.99% | -39.37% | +150.96% | 12.08B | |
| -0.07% | +3.07% | -3.76% | +54.63% | 6.19B | |
| +8.38% | +18.29% | - | - | 2.87B | |
| +0.03% | -12.02% | +29.33% | -47.78% | 1.72B | |
| -4.25% | -3.81% | - | - | 1.59B | |
| +2.32% | -0.30% | -30.41% | - | 1.29B | |
| +0.57% | -4.31% | -33.27% | -59.98% | 813M | |
| +3.19% | +0.46% | -28.16% | +214.12% | 803M | |
| Average | +0.97% | -0.82% | -21.31% | +49.26% | 5.92B | |
| Weighted average by Cap. | -0.01% | -3.16% | -34.12% | +37.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 398M 41.94M 36.11M 33.18M 31.2M 58.14M 3.99B 59.18M 393M 153M 1.94B 157M 154M 6.7B | 476M 50.1M 43.14M 39.64M 37.26M 69.45M 4.77B 70.7M 469M 183M 2.32B 188M 184M 8B |
| Net income | 31.63M 3.33M 2.87M 2.64M 2.48M 4.62M 317M 4.7M 31.19M 12.16M 154M 12.5M 12.24M 532M | 60.18M 6.34M 5.46M 5.02M 4.72M 8.79M 603M 8.94M 59.36M 23.15M 293M 23.79M 23.29M 1.01B |
| Net Debt | -95.93M -10.1M -8.7M -7.99M -7.52M -14.01M -961M -14.26M -94.61M -36.89M -467M -37.92M -37.12M -1.61B | -171M -18M -15.5M -14.24M -13.39M -24.95M -1.71B -25.4M -169M -65.71M -833M -67.55M -66.12M -2.87B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CARA Stock
- APXZF Stock
Select your edition
All financial news and data tailored to specific country editions
